Anti-inflammatory cytokine profile in human heart failure: Behavior of interleukin-10 in association with tumor necrosis factor-alpha

Japanese Circulation Journal

Volumn 63, Issue 12, 1999, Pages 951-956

  Yamaoka, Minako ^a   Yamaguchi, Seiji ^a   Okuyama, Masaki ^a   Tomoike, Hitonobu ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Heart failure; IL 10 receptor; Interleukin 10 (IL 10); Tumor necrosis factor alpha (TNF )

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION;

ADULT; AGED; DOWN-REGULATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033428974     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.951     Document Type: Article

References (41)

1. Levine B, Kalman J, Mayer L, Filit HM, Packer M: Elevation circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 223: 236-241
2. Dutka DP, Elbora JS, Delamere F, Shale DJ, Morris GK: Tumour necrosis factor a in severe congestive cardiac failure. Br Heart J 1993; 70: 141-143
3. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-566
4. Testa M, Michael Y, Lee P, Fanelli R, Loperfido F, Berman JW, et al: Circulating levels of cytokines and their endogenous modulators in patients with mild to severe heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28: 964-971
5. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-1206
6. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-389
7. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2302-2312
8. Torre-Amione G, Kapadia S, Lee J, Jean-Bernard D, Bies RD, Young JB, et al: Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711
9. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, et al: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 1997; 81: 627-635
10. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, et al: Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-1486
11. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H: Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 1997; 61: 657-664
12. Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H: Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure. J Moll Cell Cardiol 1998; 30: 2003-2012
13. Vonhof S, Brost B, Stille-Siegener M, Grumbach IM, Kreuzer H, Figulla HR: Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol 1998; 63: 237-244
14. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220
15. Fiorentino DF, Zlotnik A, Vieira P, Mossman TR, Howard M, Moore KW, et al: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822
16. Moore KW, O'Garra A, De Waal Malefty R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993; 11: 165-190
17. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin-10. J Exp Med 1991; 174: 1549-1555
18. Joyce DA, Gibbons DP, Green P, Steer JH, Feldman FM: Two inhibitors of pro-inflammatory cytokine release, interleukine-10 and interleukine-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994; 24: 2699-2705
19. Van Zee KJ, Kohno T, Fisher E, Rock CS, Moldawer LL: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845-4849
20. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldman M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527
21. Daftarin PM, Kumar A, Kryworuchko M, Diaz-Mitoma F: IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α. J Immunol 1996; 157: 12-20
22. Kurtzhals JAL, Adabayeri V, Goka BQ, A. BD., Oliver-Commey JO, Nkrumah FK, et al: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998; 351: 1768-1772
23. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, et al: Pathophysiologically relevant concentration of tumor necrosis factor-α promotes progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-1391
24. Liu Y, Wei SH-Y, Ho AS-Y, De Waal Malefyt R, Moore KW: Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152: 1821-1829
25. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S: Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16: 5894-5903
26. Iversen PO, Hart PH, Bonder CS, Lopez AF: Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells. Cancer Res 1997; 57: 476-480
27. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S: Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation 1994; 89: 955-958
28. Michel G, Mirmohammadsadegh A, Olasz E, Jarzebska-Deussen B, Muschen A, Kemeny L, et al: Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriac glucocorticisteroid in normal cultures keratinocytes. J Immunol 1997; 159: 6291-6297
29. John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B, et al: Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 (granulocyte-macrophage colony-stimulating factor, and interferon-α release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157: 256-262
30. Van der Poll T, Jansen PM, Montegut WJ, Braxton CC, Calvano SE, Stackpole SA, et al: Effect of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997; 158: 1971-1975
31. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, et al: Interleukin-10 controls interferon-α and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24: 1167-1171
32. Meisel C, Vog K, Platzer C, Randow F, Liebenthal C, Volk H-D: Differential regulation of monocytic tumor necrosi factor-α and interleukin-10 expression. Eur J Immunol 1996; 26: 1580-1586
33. Francis SE, Holden H, Holt CM, Duff GW: Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1998; 30: 215-223
34. Le Moine O, Stordeur P, Schandene L, Marchant A, De Groote D, Goldman M, et al: Adenosine enhances IL-10 secretion by human monocytes. J Immunol 1996; 156: 4408-4414
35. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF: Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-719
36. Tan JC, Indelicato SR, Narula SK, Zavodny PJ, Chou C-C: Characterization of interleukin-10 receptors on human and mouse cells. J Biol Chem 1993; 268: 21053-21059
37. Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Damell JE, Schreiber RD: Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem 1996; 271: 27954-27961
38. Jurlander J, Lai C-F, Tan J, Chou C-C, Geisler CH, Schriber J, et al: Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 1997; 89: 4146-4152
39. Weber-Nordt RM, Meraz MA, Schreiber RD: Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J Immunol 1994; 153: 3734-3744
40. Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ: Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 1996; 75: 287-290
41. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promotor. Eur J Immunogenet 1997; 24: 1-8